← Back to all trials
Recruiting
NCT05704387
Restrictive- vs Individualized Goal Directed Fluid Therapy in Liver Surgery
Conditions: Surgery-Complications
Sex: All
Ages: 18 Years – 90 Years
Phase: NA
Enrollment: 90
Sponsor: Assistance Publique - Hôpitaux de Paris
Location: France
Summary
"Low central venous pressure (low-CVP) or a restrictive fluid administration strategy is usually used worldwide during major liver resection surgery.
Although individualized goal directed fluid therapy (GDFT) has been associated with reduced morbidity and mortality in major abdominal surgery, concerns remain on blood loss when applying GDFT in liver surgery.
Indeed, GDFT could lead to a higher CVP with the risk of increased blood loss and reduced quality of the surgical field especially during liver dissection.Since evidence is scarce, this randomized controlled trial investigates the impact of a restrictive vs an individualized GDFT strategy assisted by an assisted fluid management (AFM) system on lactate level, blood loss, and postoperative morbidity including acute kidney injury (AKI) in major liver resections."
Eligibility Criteria
Inclusion Criteria:Adult patientMajor liver surgeryExclusion Criteria:-arrythmia -Linguistic barrier -Pregnant women
Source: ClinicalTrials.gov (NCT05704387). StuddyBuddy aggregates publicly available trial information.